Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.96−0.06 (-2.97%)
Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –
Compugen operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was $31.33M. The highest annual figure on record is $31.33M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.33M | – |
| FY2024 | Dec 31, 2024 | -$14.89M | – |
| FY2023 | Dec 31, 2023 | -$12.99M | – |
| FY2022 | Dec 31, 2022 | -$35.37M | – |
| FY2021 | Dec 31, 2021 | -$35.07M | – |
| FY2020 | Dec 31, 2020 | -$31.50M | – |
| FY2019 | Dec 31, 2019 | -$28.88M | – |
| FY2018 | Dec 31, 2018 | -$23.23M | – |
| FY2017 | Dec 31, 2017 | -$37.41M | – |
| FY2016 | Dec 31, 2016 | -$32.58M | – |
| FY2015 | Dec 31, 2015 | -$20.92M | – |
| FY2014 | Dec 31, 2014 | -$12.34M | – |
| FY2013 | Dec 31, 2013 | -$17.04M | – |
| FY2012 | Dec 31, 2012 | -$13.54M | – |
| FY2011 | Dec 31, 2011 | -$11.98M | – |
| FY2010 | Dec 31, 2010 | -$7.88M | – |
| FY2009 | Dec 31, 2009 | -$7.63M | – |
See a number that looks wrong?